Anavex Life Sciences Financial Overview
Anavex Life Sciences's market cap is currently $325.23M. The company's EPS TTM is $-0.11; its P/E ratio is ―; Anavex Life Sciences is scheduled to report earnings on November 25, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
